Thermo Fisher Scientific Inc. (TMO): who owns it and who trades it
As of Nov 16, 2026, TMO insiders reported 140 open-market sales worth $138M and no purchases in the last 12 months, with 56% of the sale value made under pre-set 10b5-1 plans. The largest seller was Michel Lagarde (Vice president), with $48.6M. 12 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Thermo Fisher Scientific
From the latest filingsOverall: more selling than buying. Insiders and Congress mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns TMO
2,607 funds and institutions reported TMO shares worth $169B at the end of Q2 2026, about 91% of the company. The largest holder is BlackRock, Inc. with 8.4%.
Funds and institutions (13F) 91%Everyone else 9%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 30.92M | 8.36% | $15.5B | +2% |
| Vanguard Capital Management LLC | 24.28M | 6.57% | $12.2B | No change |
| State Street Corp | 16.83M | 4.55% | $8.4B | +1% |
| FMR LLC (Fidelity) | 14.08M | 3.81% | $7.1B | +31% |
| Morgan Stanley | 10.76M | 2.91% | $5.4B | -1% |
| JPMorgan Chase & Co | 8.50M | 2.30% | $4.3B | – |
| Geode Capital Management, LLC | 8.38M | 2.27% | $4.2B | -0% |
| Franklin Resources Inc | 7.27M | 1.97% | $3.6B | +7% |
| Vanguard Portfolio Management LLC | 6.23M | 1.68% | $3.1B | +1% |
| Capital World Investors | 6.20M | 1.68% | $3.1B | -7% |
| T. Rowe Price Associates | 5.12M | 1.38% | $2.6B | -19% |
| Norges Bank | 5.09M | 1.38% | $2.6B | – |
| Capital Research Global Investors | 4.15M | 1.12% | $2.1B | -6% |
| Bank of New York Mellon Corp | 3.94M | 1.07% | $2B | +5% |
| Bank of America Corp | 3.90M | 1.05% | $2B | -30% |
| Royal Bank of Canada | 3.43M | 0.93% | $1.7B | -12% |
| Northern Trust Corp | 3.33M | 0.90% | $1.7B | -3% |
| Capital International Investors | 3.18M | 0.86% | $1.6B | -18% |
| Charles Schwab Investment Management Inc | 3.11M | 0.84% | $1.6B | +6% |
| Dodge & Cox | 3.05M | 0.83% | $1.5B | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, TMO insiders reported $0 of open-market purchases and $138M of sales. 56% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Gianluca Pettiti | President | Sale plan | 400 | $701.42 | $281K | Form 4 |
| Nov 13, 2026 | Gianluca Pettiti | President | Sale plan | 3,733 | $701.42 | $2.6M | Form 4 |
| Oct 28, 2026 | Lisa P. Britt | Vice president | Sale | 2,831 | $706.45 | $2M | Form 4 |
| Aug 31, 2026 | Gianluca Pettiti | President | Sale plan | 3,733 | $614.38 | $2.3M | Form 4 |
| Aug 31, 2026 | Gianluca Pettiti | President | Sale plan | 400 | $614.38 | $246K | Form 4 |
| Aug 24, 2026 | Marc N Casper | CEO | Sale plan | 33 | $626.59 | $20.7K | Form 4 |
| Aug 24, 2026 | Marc N Casper | CEO | Sale plan | 79 | $628.01 | $49.6K | Form 4 |
| Aug 24, 2026 | Marc N Casper | CEO | Sale plan | 62 | $628.74 | $39K | Form 4 |
| Aug 24, 2026 | Marc N Casper | CEO | Sale plan | 101 | $625.41 | $63.2K | Form 4 |
| Aug 21, 2026 | Marc N Casper | CEO | Sale plan | 321 | $629.10 | $202K | Form 4 |
| Aug 21, 2026 | Marc N Casper | CEO | Sale plan | 2,147 | $628.61 | $1.3M | Form 4 |
| Aug 21, 2026 | Marc N Casper | CEO | Sale plan | 1,791 | $627.39 | $1.1M | Form 4 |
| Aug 21, 2026 | Marc N Casper | CEO | Sale plan | 3,014 | $626.51 | $1.9M | Form 4 |
| Aug 21, 2026 | Marc N Casper | CEO | Sale plan | 2,727 | $625.46 | $1.7M | Form 4 |
| Aug 20, 2026 | Marc N Casper | CEO | Sale plan | 2,601 | $628.82 | $1.6M | Form 4 |
| Aug 20, 2026 | Marc N Casper | CEO | Sale plan | 80 | $633.99 | $50.7K | Form 4 |
| Aug 20, 2026 | Marc N Casper | CEO | Sale plan | 909 | $625.45 | $569K | Form 4 |
| Aug 20, 2026 | Marc N Casper | CEO | Sale plan | 821 | $626.83 | $515K | Form 4 |
| Aug 20, 2026 | Marc N Casper | CEO | Sale plan | 1,314 | $627.66 | $825K | Form 4 |
| Aug 20, 2026 | Marc N Casper | CEO | Sale plan | 1,250 | $629.85 | $787K | Form 4 |
| Aug 20, 2026 | Marc N Casper | CEO | Sale plan | 1,035 | $630.87 | $653K | Form 4 |
| Aug 20, 2026 | Marc N Casper | CEO | Sale plan | 1,430 | $632.01 | $904K | Form 4 |
| Aug 20, 2026 | Marc N Casper | CEO | Sale plan | 560 | $632.94 | $354K | Form 4 |
| Aug 19, 2026 | Lisa P. Britt | Vice president | Sale | 11,440 | $613.12 | $7M | Form 4 |
| Aug 11, 2026 | Michael D Shafer | Vice president | Sale plan | 11,200 | $600.00 | $6.7M | Form 4 |
| Aug 11, 2026 | Michael D Shafer | Vice president | Sale plan | 14,300 | $600.00 | $8.6M | Form 4 |
| Aug 7, 2026 | Joseph R. Holmes | Vice president | Sale | 420 | $584.81 | $246K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 12 | $587.64 | $7.1K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 7 | $593.32 | $4.2K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 94 | $577.37 | $54.3K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 114 | $579.26 | $66K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 113 | $580.71 | $65.6K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 113 | $581.85 | $65.7K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 302 | $583.35 | $176K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 1,035 | $584.41 | $605K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 530 | $585.44 | $310K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 945 | $586.52 | $554K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 228 | $587.64 | $134K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 522 | $589.52 | $308K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 495 | $590.78 | $292K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 117 | $593.31 | $69.4K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 58 | $586.53 | $34K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 6 | $577.37 | $3.5K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 4 | $579.26 | $2.3K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 2 | $579.27 | $1.2K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 4 | $580.71 | $2.3K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 3 | $580.72 | $1.7K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 5 | $581.85 | $2.9K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 2 | $581.86 | $1.2K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 18 | $583.37 | $10.5K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 63 | $584.40 | $36.8K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 30 | $585.42 | $17.6K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 32 | $589.51 | $18.9K | Form 4 |
| Aug 7, 2026 | Marc N Casper | CEO | Sale plan | 29 | $590.77 | $17.1K | Form 4 |
| Aug 6, 2026 | Lisa P. Britt | Vice president | Sale | 5,850 | $580.00 | $3.4M | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 480 | $571.05 | $274K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 1,631 | $572.43 | $934K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 2,545 | $573.53 | $1.5M | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 1,617 | $574.40 | $929K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 2,164 | $575.46 | $1.2M | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 480 | $576.46 | $277K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 451 | $577.43 | $260K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 321 | $578.67 | $186K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 311 | $579.90 | $180K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 240 | $571.00 | $137K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 660 | $572.33 | $378K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 1,200 | $573.34 | $688K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 1,008 | $574.28 | $579K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 1,060 | $575.41 | $610K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 225 | $576.09 | $130K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 361 | $577.57 | $209K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 119 | $578.93 | $68.9K | Form 4 |
| Aug 6, 2026 | Marc N Casper | CEO | Sale plan | 127 | $580.01 | $73.7K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 75 | $577.56 | $43.3K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 2,575 | $576.82 | $1.5M | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 66 | $567.94 | $37.5K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 38 | $569.13 | $21.6K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 40 | $569.69 | $22.8K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 68 | $571.50 | $38.9K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 216 | $573.08 | $124K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 590 | $574.03 | $339K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 1,113 | $574.98 | $640K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 1,464 | $576.05 | $843K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 1,289 | $576.83 | $744K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 37 | $577.56 | $21.4K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 157 | $566.25 | $88.9K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 130 | $567.92 | $73.8K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 105 | $569.24 | $59.8K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 53 | $569.76 | $30.2K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 135 | $571.49 | $77.2K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 431 | $573.08 | $247K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 1,186 | $574.03 | $681K | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 2,223 | $574.98 | $1.3M | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 2,930 | $576.05 | $1.7M | Form 4 |
| Aug 5, 2026 | Marc N Casper | CEO | Sale plan | 79 | $566.26 | $44.7K | Form 4 |
| Jul 27, 2026 | Gianluca Pettiti | President | Sale plan | 400 | $565.00 | $226K | Form 4 |
| Apr 27, 2026 | Gianluca Pettiti | President | Sale plan | 400 | $462.66 | $185K | Form 4 |
| Mar 11, 2026 | Michael D Shafer | Vice president | Sale plan | 1,607 | $499.40 | $803K | Form 4 |
| Mar 5, 2026 | Marc N Casper | CEO | Sale plan | 20 | $503.66 | $10.1K | Form 4 |
| Mar 5, 2026 | Marc N Casper | CEO | Sale plan | 264 | $519.74 | $137K | Form 4 |
Latest 100 of 140 trades in the last 12 months.
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Michel Lagarde | Executive Vice President & COO | – | $48.6M | Dec 4, 2025 |
| Marc N Casper | Chairman & CEO, Director | – | $40M | Aug 24, 2026 |
| Michael D Shafer | Executive Vice President | – | $22.5M | Aug 11, 2026 |
| Lisa P. Britt | Sr. VP and Chief HR Officer | – | $12.4M | Oct 28, 2026 |
| Frederick M. Lowery | Executive Vice President | – | $8.2M | Dec 2, 2025 |
| Gianluca Pettiti | Executive Vice President | – | $6.1M | Nov 13, 2026 |
| Joseph R. Holmes | VP & Chief Accounting Officer | – | $246K | Aug 7, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
TMO short interest
Low short interest. 1.3% of TMO shares are sold short: about 1 share in 77. Over the last 12 reports the number of shares short barely changed.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.78M TMO shares were sold short, 1.3% of the shares outstanding, down 2.1% from the report before. At the average daily volume of 2.43M shares, buying them all back would take about 2.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.78M | 1.29% | -2% | 2.43M | 2.0 |
| Oct 15, 2026 | 4.89M | 1.32% | -10% | 2.28M | 2.1 |
| Sep 30, 2026 | 5.41M | 1.46% | +8% | 2.61M | 2.1 |
| Sep 15, 2026 | 5.02M | 1.36% | -12% | 1.83M | 2.7 |
| Aug 31, 2026 | 5.69M | 1.54% | +20% | 1.68M | 3.4 |
| Aug 14, 2026 | 4.74M | 1.28% | -5% | 1.66M | 2.9 |
| Jul 31, 2026 | 4.99M | 1.35% | -6% | 2.62M | 1.9 |
| Jul 15, 2026 | 5.30M | 1.43% | -1% | 1.78M | 3.0 |
| Jun 30, 2026 | 5.35M | 1.45% | +21% | 2.44M | 2.2 |
| Jun 15, 2026 | 4.42M | 1.19% | -6% | 2.15M | 2.0 |
| May 29, 2026 | 4.69M | 1.26% | -2% | 2.82M | 1.7 |
| May 15, 2026 | 4.77M | 1.28% | -2% | 2.50M | 1.9 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded TMO
Since Nov 17, 2024, 16 members of Congress reported 9 purchases and 21 sales of TMO. The latest was a sale by Dan Newhouse on Jul 10, 2026, reported Jul 17, 2026.
Purchases 9Sales 21
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | Dan Newhouse (R-WA) | Sale | $1K–$15K | Spouse | Jul 17, 2026 | Report |
| May 7, 2026 | Dwight Evans (D-PA) | Partial sale | $1K–$15K | Self | May 15, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Oct 31, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Nov 21, 2025 | Report |
| Oct 30, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Nov 21, 2025 | Report |
| Oct 30, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Nov 21, 2025 | Report |
| Sep 23, 2025 | Val T. Hoyle (D-OR) | Sale | $1K–$15K | Spouse | Oct 10, 2025 | Report |
| Aug 19, 2025 | Kelly Morrison (D-MN) | Partial sale | $15K–$50K | Self | Sep 11, 2025 | Report |
| Aug 19, 2025 | Kelly Morrison (D-MN) | Partial sale | $1K–$15K | Self | Sep 11, 2025 | Report |
| Jul 25, 2025 | Julia Letlow (R-LA) | Purchase | $1K–$15K | Self | Jan 13, 2026 | Report |
| Jul 22, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jul 21, 2025 | Angus S. King, Jr. (I-ME) | Sale | $1K–$15K | Spouse | Aug 18, 2025 | Report |
| Jun 10, 2025 | Lisa C. McClain (R-MI) | Partial sale | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jun 6, 2025 | Val T. Hoyle (D-OR) | Purchase | $1K–$15K | Spouse | Sep 12, 2025 | Report |
| May 16, 2025 | Rick W. Allen (R-GA) | Sale | $15K–$50K | Spouse | Jun 18, 2025 | Report |
| May 15, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $15K–$50K | Self | May 31, 2025 | Report |
| May 5, 2025 | Thomas H. Kean, Jr. (R-NJ) | Purchase | $1K–$15K | Self | Jun 17, 2025 | Report |
| Apr 28, 2025 | Julia Letlow (R-LA) | Sale | $1K–$15K | Self | Jan 13, 2026 | Report |
| Apr 21, 2025 | Bruce Westerman (R-AR) | Sale | $1K–$15K | Self | May 12, 2025 | Report |
| Apr 11, 2025 | Dan Newhouse (R-WA) | Partial sale | $1K–$15K | Spouse | May 16, 2025 | Report |
| Apr 11, 2025 | Rick W. Allen (R-GA) | Sale | $15K–$50K | Spouse | May 15, 2025 | Report |
| Apr 8, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $15K–$50K | Self | Apr 28, 2025 | Report |
| Apr 7, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | May 14, 2025 | Report |
| Apr 7, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | May 8, 2025 | Report |
| Mar 27, 2025 | Greg Landsman (D-OH) | Sale | $1K–$15K | Spouse | Apr 8, 2025 | Report |
| Mar 3, 2025 | Val T. Hoyle (D-OR) | Sale | $1K–$15K | Spouse | Sep 12, 2025 | Report |
| Mar 3, 2025 | Bruce Westerman (R-AR) | Purchase | $1K–$15K | Self | Apr 16, 2025 | Report |
| Feb 25, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $1K–$15K | Self | Mar 27, 2025 | Report |
| Dec 12, 2024 | Michael A. Rulli (R-OH) | Sale | $1K–$15K | Self | Aug 7, 2026 | Report |
| Dec 11, 2024 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Thermo Fisher Scientific company events
Thermo Fisher Scientific filed 10 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 30, 2026.
- Oct 30, 2026LeadershipThermo Fisher Scientific Inc., announced that Michael D. Shafer, Executive Vice President of the Company, will retire effective December 31, 2026. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf… Filing
- Oct 21, 2026ResultsReleased financial results. Filing
- Jul 23, 2026ResultsReleased financial results. Filing
- May 26, 2026VoteReported shareholder vote results. Filing
- Apr 23, 2026ResultsReleased financial results. Filing
- Mar 24, 2026AnnouncementThermo Fisher Scientific Inc. issued a press release announcing the completion of its acquisition of Clario Holdings, Inc. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Filing
- Feb 12, 2026AgreementThermo Fisher Scientific Inc. issued $1 billion of 4.215% Senior Notes due 2031, $750 million of 4.550% Senior Notes due 2033, $1.3 billion of 4.902% Senior Notes due 2036 and $750 million of 5.546% Senior Notes due 2046 (the “2046 Notes” and, collectively with the 2031 Notes, the 2033 Notes and… Filing
- Jan 29, 2026ResultsReleased financial results. Filing
- Jan 12, 2026LeadershipEach of Michel Lagarde and Frederick M. Lowery have notified Thermo Fisher Scientific Inc. of their decisions to leave the Company to pursue other opportunities. Filing
- Dec 1, 2025AgreementThermo Fisher Scientific (Finance I) B.V., an indirect, wholly-owned finance subsidiary of Thermo Fisher Scientific Inc., issued €1,000,000,000 of Floating Rate Senior Notes due 2027 and €1,100,000,000 of 3.628% Senior Notes due 2035 (the “Fixed Rate Notes” and, together with the Floating Rate… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
How Thermo Fisher Scientific makes money
Consumables brought in 42% of Thermo Fisher Scientific's revenue ($18.7B of $44.6B) in 2025. Service was next, at 42%.
By product or service, 2025
By region, 2025
From Thermo Fisher Scientific's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 26, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money
Thermo Fisher Scientific financials
Famous investors that hold TMO
12 of the 50 well-known investors we track reported holding TMO in their latest 13F filing. The largest position is Ken Fisher's, worth $2B.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Fisher · Fisher Asset Management | Q3 2026 | 2.99M | $2B | 0.6% | +3% |
| Jeremy Grantham · GMO | Q3 2026 | 2.97M | $2B | 4.3% | +8% |
| Stephen Mandel · Lone Pine Capital | Q3 2026 | 996,686 | $673M | 4.4% | New |
| Andreas Halvorsen · Viking Global Investors | Q3 2026 | 919,626 | $621M | 1.9% | -53% |
| Larry Robbins · Glenview Capital Management | Q3 2026 | 444,245 | $300M | 5.3% | -29% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 366,008 | $247M | 0.4% | +32% |
| Dan Sundheim · D1 Capital Partners | Q3 2026 | 345,988 | $234M | 0.7% | -58% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 297,568 | $201M | 1.6% | New |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 154,647 | $104M | 0.5% | +1094% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 149,695 | $101M | 0.1% | -74% |
| Israel Englander · Millennium Management | Q3 2026 | 134,801 | $91M | 0.1% | -19% |
| Tom Gayner · Markel Group | Q3 2026 | 74,100 | $50M | 0.4% | +1% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named TMO in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 5, 2026 | FMR LLC | 13G | 6.0% |
| Nov 5, 2026 | FMR LLC | 13G | 6.0% |
Questions about Thermo Fisher Scientific Inc. (TMO) stock
Who owns the most TMO stock?
The largest reported owner of Thermo Fisher Scientific Inc. (TMO) is BlackRock, Inc., with 8.4% of the company. In total, 2,607 funds and institutions reported holding TMO at the end of Q2 2026, together about 91% of the shares. See the largest owners.
Are TMO insiders buying or selling?
In the last 12 months, TMO insiders reported no open-market purchases and 140 sales worth $138M. The latest trade was on Nov 13, 2026. See every trade.
What is the short interest in TMO?
As of Oct 30, 2026, 4.78M TMO shares were sold short, 1.3% of the shares outstanding, down 2.1% from the report before. At the average daily volume of 2.43M shares, buying them all back would take about 2.0 trading days (days to cover). See the history.
Have members of Congress traded TMO?
Yes. 16 members of Congress reported 9 purchases and 21 sales of TMO since Nov 17, 2024. The latest was reported on Aug 7, 2026. See the trades.
How does Thermo Fisher Scientific make money?
Consumables brought in 42% of Thermo Fisher Scientific's revenue ($18.7B of $44.6B) in 2025. Service was next, at 42%. See the full split.
Which famous investors hold TMO?
12 of the 50 well-known investors we track reported TMO in their latest 13F filing, including Ken Fisher, Jeremy Grantham, Stephen Mandel. The largest position is worth $2B. See all holders.
Executive pay
Thermo Fisher Scientific's chief executive was paid a total of $79.9M for the year ended Dec 31, 2025, up 162% from $30.4M the year before. In the last 12 months, Thermo Fisher Scientific's executives and directors bought no stock on the open market and sold $138M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.